GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 96 filers reported holding GENERATION BIO CO in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,399 | -70.2% | 16,728 | -56.8% | 0.00% | – |
| Q2 2023 | $212,817 | +292.8% | 38,694 | +207.1% | 0.00% | – |
| Q1 2023 | $54,180 | +10.3% | 12,600 | +0.8% | 0.00% | – |
| Q4 2022 | $49,101 | -56.9% | 12,494 | -41.8% | 0.00% | – |
| Q3 2022 | $114,000 | -68.2% | 21,482 | -60.7% | 0.00% | – |
| Q2 2022 | $359,000 | +0.8% | 54,639 | +12.7% | 0.00% | – |
| Q1 2022 | $356,000 | +75.4% | 48,488 | +68.9% | 0.00% | – |
| Q4 2021 | $203,000 | -6.0% | 28,706 | +233.8% | 0.00% | – |
| Q3 2021 | $216,000 | -58.1% | 8,600 | -55.2% | 0.00% | – |
| Q2 2021 | $516,000 | -63.7% | 19,197 | -61.6% | 0.00% | – |
| Q1 2021 | $1,422,000 | +244.3% | 49,983 | +274.3% | 0.00% | – |
| Q3 2020 | $413,000 | -96.4% | 13,353 | -97.5% | 0.00% | -100.0% |
| Q2 2020 | $11,405,000 | – | 543,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $58,614,000 | 5.38% |
| Yiheng Capital Management, L.P. | 1,975,146 | $13,984,000 | 0.71% |
| Artal Group S.A. | 2,814,191 | $19,924,000 | 0.54% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,613,000 | 0.34% |
| Bellevue Group AG | 3,872,180 | $27,416,000 | 0.28% |
| Casdin Capital, LLC | 1,324,275 | $9,376,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,500,000 | $24,780,000 | 0.12% |
| BVF INC/IL | 189,050 | $1,338,000 | 0.05% |
| PDT Partners, LLC | 36,843 | $261,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 17,739 | $126,000 | 0.02% |